Literature DB >> 11354637

Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genes.

M Neerman-Arbez1, P de Moerloose, A Honsberger, G Parlier, B Arnuti, C Biron, J Y Borg, S Eber, E Meili, K Peter-Salonen, L Ripoll, C Vervel, R d'Oiron, P Staeger, S E Antonarakis, M A Morris.   

Abstract

Congenital afibrinogenemia is an autosomal recessive disorder characterized by the complete absence of detectable fibrinogen. We previously identified the first causative mutations for this disease in a non-consanguineous Swiss family. These were homozygous deletions of approximately 11 kb of the fibrinogen alpha chain gene (FGA). Our subsequent study revealed that the majority of cases were attributable to truncating mutations in FGA, with the most common mutation affecting the donor splice site in FGA intron 4 (IVS4+1 G-->T). Here, we report 13 further unrelated patients with mutations in FGA, confirming the relative importance of this gene compared with FGG and FGB in the molecular aetiology of afibrinogenemia. Three other patients were homozygous for mutations in FGG. Eight novel mutations were identified: five in FGA and three in FGG. Sufficient mutation data is now available to permit an effective strategy for the genetic diagnosis of congenital afibrinogenemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11354637     DOI: 10.1007/s004390100469

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  7 in total

1.  Molecular analysis of afibrinogenemic mutations caused by a homozygous FGA1238 bp deletion, and a compound heterozygous FGA1238 bp deletion and novel FGA c.54+3A>C substitution.

Authors:  Yuka Takezawa; Fumiko Terasawa; Kazuyuki Matsuda; Mitsutoshi Sugano; Aiko Tanaka; Mitsuhiro Fujiwara; Keigo Kainuma; Nobuo Okumura
Journal:  Int J Hematol       Date:  2012-05-26       Impact factor: 2.490

2.  Fibrinogen stabilizes placental-maternal attachment during embryonic development in the mouse.

Authors:  Takayuki Iwaki; Mayra J Sandoval-Cooper; Melissa Paiva; Takao Kobayashi; Victoria A Ploplis; Francis J Castellino
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

3.  Hypofibrinogenemia with preserved hemostasis and protection from thrombosis in mice with an Fga truncation mutation.

Authors:  Woosuk S Hur; David S Paul; Emma G Bouck; Oscar A Negrón; Jean-Marie Mwiza; Lauren G Poole; Holly M Cline-Fedewa; Emily G Clark; Lih Jiin Juang; Jerry Leung; Christian J Kastrup; Tatiana P Ugarova; Alisa S Wolberg; James P Luyendyk; Wolfgang Bergmeier; Matthew J Flick
Journal:  Blood       Date:  2022-03-03       Impact factor: 22.113

4.  Identification of novel mutations in congenital afibrinogenemia patients and molecular modeling of missense mutations in Pakistani population.

Authors:  Arshi Naz; Arijit Biswas; Tehmina Nafees Khan; Anne Goodeve; Nisar Ahmed; Nazish Saqlain; Shariq Ahmed; Ikram Din Ujjan; Tahir S Shamsi; Johannes Oldenburg
Journal:  Thromb J       Date:  2017-09-12

Review 5.  Human Fibrinogen: Molecular and Genetic Aspects of Congenital Disorders.

Authors:  Giovanni Luca Tiscia; Maurizio Margaglione
Journal:  Int J Mol Sci       Date:  2018-05-29       Impact factor: 5.923

Review 6.  Extension of the Human Fibrinogen Database with Detailed Clinical Information-The αC-Connector Segment.

Authors:  Zofie Sovova; Klara Pecankova; Pavel Majek; Jiri Suttnar
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

7.  Effects of berberine hydrochloride on immune response in the crab Charybdis japonica.

Authors:  Tian-Heng Gao; Ming-Ming Han; Hui Zhou; Chen-Xi Zhu; Ying Yang; Zakaria Zuraini; Yan-Xia Guo; Qi-Chen Jiang
Journal:  BMC Genomics       Date:  2022-08-11       Impact factor: 4.547

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.